Global Markets Direct
Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.
... licensing opportunities by identifying windows of opportunity to fill portfolio gaps. Exploit collaboration and partnership opportunities with Molecular Insight Pharmaceuticals, Inc.. Avoid Intellectual Property Rights related issues. Explore the dormant and discontinued projects of Molecular Insight ...
Apr, 2013 51 pages... Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Sareum Holdings plc - Product Pipeline Review - 2013” provides data on the ... class, target and major milestones. Recent updates of the Sareum Holdings plc’s pipeline in the last quarter. Key discontinued and dormant ...
Apr, 2013 60 pages... Market Direct’s pharmaceuticals report, “FAES Farma SA - Product Pipeline Review - 2013” provides data on the FAES Farma SA’s research and development focus. ... , therapeutic class, target and major milestones. Recent updates of the FAES Farma SA’s pipeline in the last quarter. Key discontinued and dormant ...
Apr, 2013 51 pagesMomenta Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Momenta Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Momenta Pharmaceuticals, Inc.’s research and development focus. The report includes information on ...
Apr, 2013 51 pages... Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Forest Laboratories, Inc. - Product Pipeline Review - 2013” provides data on the ... stages of drug development, including the combination treatment modalities, across the globe. Product profiles for late stage and clinical stage ...
Apr, 2013 126 pages... , Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Pharmacyclics, Inc. - Product Pipeline Review - 2013” provides data on the Pharmacyclics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with ...
Apr, 2013 80 pages... Market Direct’s pharmaceuticals report, “Genentech, Inc. - Product Pipeline Review - 2013” provides data on the Genentech, Inc.’s research and development focus. ... class, target and major milestones. Recent updates of the Genentech, Inc.’s pipeline in the last quarter. Key discontinued and dormant projects ...
Apr, 2013 218 pagesNovartis AG – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2013” provides data on the Novartis AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest ...
Apr, 2013 936 pagesGenerex Biotechnology Corporation – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Generex Biotechnology Corporation - Product Pipeline Review - 2013” provides data on the Generex Biotechnology Corporation’s research and development focus. The report includes ...
Apr, 2013 96 pages... key players involved in the therapeutic development for Epidermolysis Bullosa. Epidermolysis Bullosa - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Apr, 2013 40 pages... key players involved in the therapeutic development for Arrhythmias. Arrhythmias - Pipeline Review, Half Year is built using data and information sourced ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons ...
Apr, 2013 43 pages... Market Direct’s pharmaceuticals report, “CanBas Co., Ltd. - Product Pipeline Review - 2013” provides data on the CanBas Co., Ltd.’s research and development focus. ... stages of drug development, including the combination treatment modalities, across the globe. Product profiles for late stage and clinical stage ...
Apr, 2013 35 pages... reviews key players involved in the therapeutic development for Cerebral Palsy. Cerebral Palsy - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons to ...
Apr, 2013 51 pages... Ltd. overview including business description, key information and facts, and its locations and subsidiaries. Review of current pipeline of Daewoong Pharmaceutical Co., Ltd. human therapeutic division. Overview of pipeline therapeutics across various therapy areas. Coverage of current pipeline molecules in ...
Apr, 2013 84 pages... Market Direct’s pharmaceuticals report, “Eisai Co., Ltd. - Product Pipeline Review - 2013” provides data on the Eisai Co., Ltd.’s research and development focus. ... stages of drug development, including the combination treatment modalities, across the globe. Product profiles for late stage and clinical stage ...
Apr, 2013 284 pages... from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Influenza B Infections pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to ...
Apr, 2013 39 pages... Ltd. overview including business description, key information and facts, and its locations and subsidiaries. Review of current pipeline of Kissei Pharmaceutical Co., Ltd. human therapeutic division. Overview of pipeline therapeutics across various therapy areas. Coverage of current pipeline molecules in ...
Apr, 2013 77 pages... Market Direct’s pharmaceuticals report, “Novogen Limited - Product Pipeline Review - 2013” provides data on the Novogen Limited’s research and development focus. ... class, target and major milestones. Recent updates of the Novogen Limited’s pipeline in the last quarter. Key discontinued and dormant projects ...
Apr, 2013 56 pages... Market Direct’s pharmaceuticals report, “Biotron Limited - Product Pipeline Review - 2013” provides data on the Biotron Limited’s research and development focus. ... class, target and major milestones. Recent updates of the Biotron Limited’s pipeline in the last quarter. Key discontinued and dormant projects ...
Apr, 2013 35 pagesAcadia Pharmaceuticals Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “ACADIA Pharmaceuticals Inc. - Product Pipeline Review - 2013” provides data on the ACADIA Pharmaceuticals Inc.’s research and development focus. The report includes information on current ...
Apr, 2013 66 pages
